Open for discussion.

Glenn Halpryn buys into CDSI and becomes director per 8K filing today. Mr. Halpryn was involved in finding shells for several of Dr. Frost's reverse merger companies.

Glenn Halpryn profile on Forbes.com:
http://people.forbes.com/profile/glenn-l-halpryn/20346

Current quote: $0.071 x $0.105
He paid $0.10 per share for 150,000 shares.

8K Filing:
On April 23, 2010, CDSI Holdings Inc. (the “Company”) entered into a stock purchase agreement with Glenn Halpryn, pursuant to which the Company sold to Mr. Halpryn 150,000 shares of the Company’s common stock, par value $0.01 per share (the “Shares”), for an aggregate purchase price of $15,000, or $0.10 per Share. The Shares are restricted securities and no registration rights have been granted. The issuance of the Shares is exempt from the registration requirements under the Securities Act of 1933, as amended, pursuant to Section 4(2) thereof, because the transaction does not involve a public offering.

Item 5.02 Department of Directors of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officer.

On April 23, 2010, the Company’s Board of Directors appointed Glenn Halpryn to the Board until his resignation or until a successor is duly elected. Mr. Halpryn was also appointed to the Company’s Audit Committee on April 23, 2010.

Glenn L. Halpryn, 49, has been the Chief Executive Officer and a Director of Transworld Investment Corporation, a private investment company, since June 2001. Mr. Halpryn currently serves as a Director of Sorrento Therapeutics (OTCBB:SRNE.OB), a biopharmaceutical company, Castle Brands Inc. (AMEX:ROX), a developer and international marketer of premium branded spirits, and SearchMedia Holdings Limited (AMEX:IDI), a billboard and in-elevator advertising company. Since 2008, Mr. Halpryn has also served as a Director of Winston Pharmaceuticals, Inc. (OTCBB:WPHM.OB), a pharmaceutical company specializing in skin creams and pain medications. From October 2002 to September 2008, Mr. Halpryn served as a Director of Ivax Diagnostics, Inc. (AMEX:IVD). Mr. Halpryn served as Chairman of the Board and Chief Executive Officer of Orthodontix, Inc. (now Protalix Bio Therapeutics, Inc.) (AMEX:PLX) from April 2001 to December 2006. From April 1988 to June 1998, Mr. Halpryn was Vice Chairman of Central Bank, a Florida state-chartered bank. Since June 1987, Mr. Halpryn has been the President of and a beneficial holder of stock of United Security Corporation, a broker-dealer registered with FINRA.

http://www.sec.gov/Archives/edgar/data/1023994/000095012310040691/c99817e8vk.htm

I OWN STOCK IN CDSI PURCHASED ON THE OPEN MARKET.